Seastar Medical Holding Corp (ICU) - Form 8-K Summary
Business Context and Reporting Period
Seastar Medical Holding Corporation, a Delaware corporation, filed this Current Report on Form 8-K on May 14, 2025. The filing announces the Company's financial condition and results of operations for the fiscal year and quarter ended March 31, 2025. The Company is designated as an emerging growth company.
Key Financial Metrics
The provided filing text serves as a cover document referencing a press release (Exhibit 99.1) for detailed data. Consequently, the text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes
The filing text does not contain specific data regarding material changes versus prior periods. It only confirms the issuance of a press release detailing the results for the period ended March 31, 2025.
Guidance, Outlook, and Risks
This 8-K filing does not include specific management commentary, forward-looking guidance, risk factors, or contingencies within the body text. The document explicitly states that the information is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, meaning it is not subject to the liabilities of that section and shall not be deemed incorporated by reference into other filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 14, 2025) for actual revenue, net income, and cash flow figures.
- Verify the specific details of the fiscal year and quarter ended March 31, 2025, as the 8-K text only references the announcement.
- Confirm the status of the Company's emerging growth company election and any related accounting standard transitions.
- Check the Nasdaq Stock Market for trading updates on Common Stock (ICU) and Warrants (ICUCW) following the announcement.